The Massachusetts Life Sciences Center. Massachusetts League of Community Health Centers Community Health Institute May 11, 2011



Similar documents
The Massachusetts Life Sciences Center

BRIDGING THE GAPS: ENTREPRENEURSHIP, SCIENCE and GENDER

Academic Health Center Six-Year Strategic Plan October 20, 2000

EXECUTIVE SUMMARY Prepared for: Pharmaceutical Research and Manufacturers of America (PhRMA) Prepared by: Battelle Technology Partnership Practice

Never want to leave college?

Profile of Biomedical Research and Biotechnology Commercialization. Boston-Worcester-Lawrence Consolidated Metropolitan Statistical Area

EXPANSION. The Hormel Institute University of Minnesota LIVE LEARNING CENTER

Executive Summary. Principal Findings

Boston University Metropolitan College/ School of Medicine Biomedical Laboratory and Clinical Sciences (BLCS) Strategic Plan Outline

RECOMMEND APPROVAL OF MASTER OF SCIENCE IN BIOMEDICAL SCIENCE AND BIOTECHNOLOGY AT UNIVERSITY OF COLORADO DENVER

OR Workshop: Creating Smarter Operating Rooms. Introducing LiveData Smart Integration Software For the Operating Room of the Future

The Commercialization of Technology Concepts into Medical Products

BIOTECHNOLOGY. Bouvé College of Health Sciences College of Science. Networked for Success. Networked for Industry. Networked for Life.

Umass Medical School China Program Brochure

Leveraging Sponsors to Advance Careers

Opportunities and Challenges in Technology Transfer and Start Up Creation in a Research University Rick McCullough Vice President for Research

HOT TOPICS IN IN HEALTH CARE REFORM

Corporate Prospectus January 2015

SMALL BUSINESS INNOVATION RESEARCH (SBIR) SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) GRANT APPLICATIONS

Executive Sponsor for Quality through Engagement (QTE) Executive Sponsor for Asian Affinity Group Executive Sponsor for Hershey Track and Field Games

A Texas Life Science Perspective. Thomas R. Kowalski President Texas Healthcare and Bioscience Institute

1. What are the key strengths and weaknesses of the UK s innovation system in relation to business-university collaboration?

The University of Maryland School of Medicine

Commonwealth Advanced Data Analytics Alliance & The President s Precision Medicine Initiative

LIEUTENANT GOVERNOR MURRAY AND MASSACHUSETTS LIFE SCIENCES CENTER ANNOUNCE EQUIPMENT AND SUPPLY MATCHING GRANTS FOR PUBLIC HIGH SCHOOLS

LIFE SCIENCES QUEENSLAND LIMITED (LSQ) Mario Pennisi

2015 Russian Nanotechnology Investment Enabling Technology Leadership Award

Graduate Research and Education: New Initiatives at ORNL and the University of Tennessee

Sarah A. Haecker, PhD 1782 Humboldt Avenue Minneapolis, Minnesota

COLLEGE OF ARTS AND SCIENCES NATURAL SCIENCES AND MATHEMATICS

Regional Extension Centers: Support for EMR Adoption and Workforce Development

HR 2272 Conference Report STEM Education Provisions Summary

Research Opportunities

Join our scientific talent community

Biotechnology in North Carolina

Master of Science in BIOINFORMATICS. > information. > insight. > innovation

A Strategic Plan for Research Growth at UNC Charlotte

How To Become A Scientist

How Big Data Is Hoping To Power Predictive Analytics

Florida Has Implemented Promising Biotechnology Initiatives, But Faces Challenges

Highlights of Cybersecurity Efforts in Other States. JCOTS Cybersecurity Advisory Committee

Degrees in Science (& Physics)

Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research

Vermont Council. Vermont Science & Technology Plan

OFFICE OF PERFORMANCE MANAGEMENT & OVERSIGHT FISCAL 2014 ANNUAL REPORT GUIDANCE

CARMEN A. PULIAFITO, M.D., M.B.A. DEAN, KECK SCHOOL OF MEDICINE OF THE UNIVERSITY OF SOUTHERN CALIFORNIA

BIOLOGICAL SCIENCES. What can I do with this degree?

Department of Legislative Services

LOCATION & SCOPE EMPLOYEES/PHYSICIANS/ RESEARCHERS/FACULTY

CURRICULUM AND STUDENT GUIDE. Cellular and Molecular Pharmacology and Physiology (CMPP) Graduate Program University of Nevada, Reno

The World is Flat and Beckoning

Agenda Item 3. Discovery to Product Accelerator

State Funds Resulted in Expanded Research at Oregon Health & Science University

OVERVIEW & ECONOMIC IMPACT OF RESEARCH PARKS. Greg Hyer, Associate Director University Research Park University of Wisconsin Madison

The Role of Research Institutions in the Formation of the Biotech Cluster in Massachusetts

Resumen Curricular de los Profesores. Jesse Boehm

HINJ and New Jersey s Life Sciences Community

Keys To IP Collaborations With Universities: Part 3

TO MEMBERS OF THE COMMITTEE ON EDUCATIONAL POLICY AND THE COMMITTEE ON HEALTH SERVICES: ACTION ITEM

Northeast Ohio Medical University (NEOMED) Chair of Pharmaceutical Sciences Search

HARVARD MEDICAL SCHOOL

Pharmaceutical Sciences

This report is supported by members of United for Medical Research and a supplemental UMR contribution from Life Technologies.

Six Big Ideas Webinar Series - SUNY and the Entrepreneurial Century

Department Chair, Physical Therapy

Introduction. The Healthcare Sector in Asia - Current Situation. Projected Healthcare Expenditure

Harvard and the Massachusetts Economy FACTS & IMPACT

Pharmaceutical & Chemical Sciences Graduate Program

Master of Philosophy (MPhil) and Doctor of Philosophy (PhD) Programs in Life Science

2019 Healthcare That Works for All

Lilly Covance Strategic Alliance From Vision to Results. Adrienne Takacs, PhD Jonathan Koch, MBA

STARTUP NATION: Israel s Surprising Economic Success In The Face Of Adversity (And What It Means For SC)

Propel Careers Career Development Seminars

Faculty of of Science

Health Reform s New Frontier: Balancing Cost, Value and Innovation

Ph.D. in Bioinformatics and Computational Biology Degree Requirements

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more:

Status Report: Cancer Biomedical Informatics Grid (cabig ) Oversight ad hoc Subcommittee. Board of Scientific Advisors November 7, 2011

Technology funding opportunities at the National Cancer Institute

A History of the Division of Graduate Education and Research

Growing Talent: MEETING THE EVOLVING NEEDS OF THE MASSACHUSETTS LIFE SCIENCES INDUSTRY

Boston Healthcare Careers Consortium

Member Institutions. The leading recruiting source for postgraduate life scientists. Bio Careers reaches MDs and postgraduate life

Trends in Instructional Activity in STEM Disciplines at the University of Wisconsin Madison

THE LINCOLN INSTITUTE OF HEALTH

Harvard University Managing Director of Environmental Health and Safety

Proposal to establish the Department of Biomedical Engineering (BME) Prepared by Dean Michael Cain (SMBS) and Dean Liesl Folks (SEAS) February 6, 2014

WEAVE Program Inventory (as of July 2014)

BIOSCIENCES COURSE TITLE AWARD

2014 Wells Fargo Healthcare Conference June 17, 2014 NYSE: Q

Wither the Global Talent Pool?

Outside Activity Report: What Do I Need to Report? Copyright Harvard Medical School. All Rights Reserved.

Ross Leimberg MBA 2012 BLAVATNIK FELLOWSHIP

U.S. News: Measuring Research Impact

Curricular Affairs Committee of the Faculty Senate

CAREER SYNOPSIS Jean K. Brown, PhD, RN, FAAN

CAMPAIGN: Transforming MEDICINE Beyond IMAGINATION

Bioethics Education in Professional Science Master s Programs at California State University Channel Islands

AP Recruit: Basic Qualifications

Bayer Invests Heavily in R&D and is committed to innovation Sustained Innovation Output from all Subgroups

Transcription:

The Massachusetts Life Sciences Center Massachusetts League of Community Health Centers Community Health Institute May 11, 2011 0

Massachusetts: A Global Leader in Life Sciences The Massachusetts Life Sciences Supercluster: The world s leading innovation pipeline: The Milken Institute s 2010 ratings rank Massachusetts #1 for technology innovation World-class academic and medical institutions leading the way in life sciences research A talented workforce All industry sectors -- biotechnology, pharmaceuticals, medical devices, diagnostics and bioinformatics Government leadership, through our state s 10-year, $1 billion Life Sciences Initiative (enacted by the Massachusetts Legislature in June 2008) 1

Life Sciences: Critical to our Innovation Economy Over 80,000 Massachusetts employees work in the life sciences* Medical devices are Massachusetts #1 export, representing 13% of exports in 2010 Life sciences is a leading source of new company formation, and venture capital investment Massachusetts receives more per-capita in NIH research funding than any other state ($2.4 billion total in FY 10), a key contributor to job creation and innovation 2001-2008: 42.6% job growth in Mass biopharma State lost 56,000 jobs in other sectors Life sciences companies and research institutions are expanding and creating jobs across the Commonwealth even as other sectors are shrinking *excludes health care delivery 2

The Challenge: Competition at Home and Abroad Other states and nations are catching up: California -- $3 billion initiative focused on stem cell research North Carolina Invested more than $1.2 billion in life sciences over the past ten years China, India and Korea -- investing billions of dollars in bioparks, workforce development and R&D facilities Europe (e.g., Germany, Italy, Spain, Switzerland and the U.K.) -- active initiatives for life sciences expansion California Institute for Regenerative Medicine Pegasus BioPark, Dalian, China Research Technology Park, North Carolina 3

The Massachusetts Life Sciences Center: Who We Are and What We Do Vision: The Massachusetts Life Sciences Center administers the state s 10-year, $1B life sciences initiative. We develop and offer best practice programs that fund innovative economic development initiatives in the Massachusetts life sciences Supercluster, but also may have relevance for other technology sectors Mission: Serve as the hub of the Massachusetts life sciences Supercluster Create jobs and drive economic development Encourage innovation through investments in good science and good business Strengthen and protect Massachusetts global leadership position in the life sciences by supporting our academic medical centers, research institutions and universities; contributing to workforce development, and creating an industry-friendly environment Accelerate the commercialization of promising treatments, therapies and cures 4

Life Sciences Initiative Investment Tools FY 10 = $30M FY 11 = $34M FY 10 = $25M FY 11 = $25M 10 years $1 billion Investment FY 10 = $10M FY 11 = $10M 5

MLSC Strategy Summary: Programs Tie Directly to Strategic Priorities Vision and Mission Strategic Priorities Programs: Competitiveness: Faculty grants and infrastructure Focus Areas Pipeline: Industry sponsored (translational) research; New Investigators, and Young Companies Workforce: Internships; Equipment and Supplies for Training Programs Infrastructure and Ecosystem: Capital Projects; Convening Retention and Investment: Tax Incentives Strategic priorities: Competitiveness of the State s academic institutions Pipeline of new therapies, technologies, molecules, etc Supply and distribution of life sciences workers with skills that are aligned with stakeholder needs LS infrastructure and Ecosystem Retention and growth of LS companies Programs, Products, Services Impact 6

The Massachusetts Life Sciences Center Board of Directors Secretary of Housing and Economic Development Gregory Bialecki Secretary of Administration and Finance Jay Gonzalez President of the University of Massachusetts System Jack Wilson, Ph.D. A CEO of a Massachusetts-based life sciences corporation Abbie Celniker, CEO, Taligen Therapeutics A researcher involved in the commercialization of biotechnology, pharmaceuticals or medical diagnostic products Lydia Villa-Komaroff, Board Member and CSO, Cytonome/ST A physician licensed to practice medicine in the Commonwealth and affiliated with an academic medical center OPEN A person with financial expertise in the life sciences Joshua Boger, Ph.D., Former President & CEO, Vertex 7

Massachusetts Life Sciences Center Scientific Advisory Board CHAIR: Harvey Lodish, Ph.D., Whitehead Institute, and Professor of Biology and of Bioengineering, MIT Academia Venture Capital Gary Borisy, Ph.D., Director and CEO, Marine Biological Laboratory James J. Collins, Ph.D., Professor of Biomedical Engineering, Boston University George Q. Daley, M.D., Ph.D., Children's Hospital Boston, Harvard Medical School, Harvard Stem Cell Institute Lila Gierasch, Ph.D., Professor, Biophysical Chemistry, Department of Biochemistry, University of Massachusetts Amherst Richard A. Goldsby, Ph.D., John Woodruff Simpson Lecturer and Professor of Biology, Amherst College Lita L. Nelson, Director, Technology Licensing Office, Massachusetts Institute of Technology Allison Taunton-Rigby, Ph.D., CEO, RiboNovix, Inc. David Walt, Ph.D., Robinson Professor of Chemistry and Howard Hughes Medical Institute Professor at Tufts University School of Medicine Philip Zamore, Ph.D., Professor, Biochemistry and Molecular Pharmacology, UMass Medical School Industry James Barry, Ph.D., Former Vice President, Corporate Research and Advanced Technology Development, Boston Scientific Doug Cole, M.D., General Partner, Flagship Ventures Jonathan Fleming, M.P.A., Managing General Partner, Oxford Bioscience Partners Jean M. George, M.B.A., Partner, Advanced Technology Ventures Jeffrey Leiden, M.D., Ph.D., Managing Director, Clarus Ventures Rainer Fuchs, Ph.D., Vice President, Executive Director, Biogen Idec Innovation Incubator Alan E. Smith, Ph.D., Chief Scientific Officer, Genzyme Corp. 8

The Bottom Line Life Sciences Center s Impact: June 08 February 11 Matching Investments Attracted = $706 M Job Potential = 7,038 Public Dollars Invested = $213.8 M Grants to Academic Organizations and Medical Centers Grants for Shovel Ready Capital Projects Investments in Life Sciences Companies 3 X multiplier Corporate Investors NIH Private Foundations Institutes Other Private Investors Academic Institutions Permanent Building Trades 9

Making Massachusetts Life Sciences Ready Life Sciences Center investments already have contributed to the creation of more than one million square feet of new laboratory and manufacturing space. $500 million in capital funding over ten years $300 million in targeted investments (legislative earmarks) $200 million discretionary $131 million committed thus far to six job-creating capital projects Investment: Dana-Farber/UMass Boston Center for Personalized Cancer Therapy The Center has awarded $2 million for a joint Center for Personalized Cancer Therapy (CPCT) on the UMass Boston campus. The project is a joint program of UMass Boston and the Dana- Farber/Harvard Cancer Center. The CPCT will seek to reduce healthcare costs, and reduce cancer disparities among low-income, non-majority and other inadequately served, diverse populations. Marine Biological Laboratory: Before and After 10

Strengthening our World Class Academic Institutions Life Sciences Center Research Matching Grant Program: accelerating the translation of treatments and therapies from the research bench to the bedside Supporting promising scientific research ($13.6 million - matched dollar for dollar) Funding 21 new investigators ($5.1 million) Helping five universities and academic medical centers compete for top faculty ($3.75 million) Funding research collaborations between eight industry and academic partners ($4.8 million) New Investigator Investment: Jesse Mager at UMass Amherst Grant of $98,666 per year for three years; supports Mager s functional assessment of epigenetic regulatory genes in vivo. Investment: Raindance Technologies (Lexington) and Harvard School of Engineering & Applied Sciences Grant of $250,000 per year for three years; supports development of a functional fluorescent-activated cell sorter 11

Supporting Workforce Development in Classrooms Equipment & Supplies Program for Skills Training and Education New MLSC program for: Vocational technical schools Community colleges Workforce training organizations Awards grants of up to $250,000 per institution for equipment and supplies that support life sciences training Industry match is required for funding above $100,000 First round of awards made on Feb 23 rd 2011 Awards made to 32 institutions across Massachusetts; $3.4 million investment Over $600k in additional matching funds provided by industry sponsors Banafsheh Salamat, head of the Science Department at Lynn Vocational Technical Institute, after receiving a shipment of lab equipment and supplies from Vertex Pharmaceuticals. Vertex matched with an in-kind contribution the Center s recently announced Equipment and Supply Grant for LVTI. 12

Supporting Workforce Development in the Real World Internship Challenge Program: Funds interns working at companies with fewer than 100 employees -- up to $7,200 for twelve weeks of work 2009: 104 interns placed at 59 life sciences companies and research institutions across the state 2010: Over 900 applicants; 170 interns placed at 93 companies across the state Over 55 participating interns were offered full or part-time jobs at the conclusion of their internships Matt Gethers, 2009 Life Sciences Internship Challenge participant and recent MIT graduate with a degree in biological engineering, at the lab space of Ginkgo BioWorks in Boston. Photo courtesy of Bay State Banner/Sandra Larson Investment: Nuclea Biotechnologies (Pittsfield) Nuclea hired three students as interns: Sean Donovan of Pittsfield, senior biology major at Mass College of Liberal Arts; Courtney Stanford of Pittsfield, recent graduate of RIT with a degree in chemistry; and Daniel Zuber of Lenox, a biology major at Clark University. Donovan has accepted a full-time job at the company. 13

Helping Life Sciences Companies Grow Accelerator Program: Working capital for early-stage life sciences companies $9 million in loans awarded to fifteen early-stage companies SBMG Program:* Funding to match federal small business grants (SBIR & STTR) $1.5 million awarded to three life sciences companies Tax Incentive Program: Incentives for companies to locate and grow jobs in Massachusetts Center can commit up to $25 million/year Companies commit to creating a certain number of jobs in the year following award 2010 awards made to 30 companies, promising to create more than 900 jobs in 2011 Investments: Good Start Genetics (Boston) $500k Accelerator Loan in 2009. Leveraged by GSG to raised $18 million in private financing. Repaid with interest in less than two years. Sunovian (formerly Sepracor) (Marlborough) $750k Tax Incentive in 2009 based on commitment to create 25 jobs in 2010. Created more than 85 new jobs, and received a 2010 tax incentive of $943,000. *Second round of applications currently under review 14

Leveraged Impact Corporate Consortium Program The Center continues to highly leverage the public tax dollars that we invest by attracting matching dollars from the private and non-profit sectors. Johnson & Johnson agreed to participate in our Corporate Consortium Program for a second year In FY 10, Sanofi becomes the second member of the program J&J and Sanofi each commit a minimum of $250,000 per year for two years to match investments made by the Center in early-stage companies. 15

Attracting and Retaining Companies Company officials cite Massachusetts Life Sciences Initiative, talented workforce, and leading research institutions as important reasons for choosing the state. Italian amniotic stem cell company Biocell Center opens its North American Headquarters in Medford, Massachusetts. 16

Keeping in Touch www.masslifesciences.com News updates Program Information Application portal Life Sciences Center Email List 3,000 recipients Weekly event listings Sign up today! 17